Marcain Spinal Tung (Bupivacaine Hydrochloride)

Bupivacaine is a long‑acting amide local anesthetic used to achieve regional nerve block.

• Surgical procedures: provides local anesthesia for a variety of operative interventions.
• Spinal anesthesia: produces sensory and motor block for lower‑body surgeries and obstetric procedures.
• Peripheral nerve blocks: offers targeted analgesia for limb surgeries and postoperative pain control.

• Bupivacaine reversibly blocks voltage‑gated sodium channels on neuronal membranes, preventing the influx of sodium ions required for depolarisation. This inhibition stops the generation and propagation of nerve impulses, resulting in loss of sensation and, at higher concentrations, motor blockade in the targeted area.

Bupivacaine may cause a range of adverse reactions following administration.

Common Side Effects

• Hypotension: transient drop in blood pressure after spinal injection.
• Bradycardia: slowed heart rate, especially with high spinal levels.
• Dizziness or light‑headedness: related to autonomic blockade.
• Injection‑site discomfort: mild pain or burning at the puncture site.

Serious or Rare Side Effects

• Cardiac arrhythmias or cardiac arrest: due to systemic toxicity.
• Seizures: result of central nervous system toxicity at high plasma concentrations.
• Respiratory depression or apnea: severe CNS depression leading to inadequate breathing.
• Prolonged motor block: extended loss of muscle function beyond expected duration.
• Allergic reactions: including rash, urticaria, or anaphylaxis.

When using Marcain Spinal Tung, clinicians should observe several safety measures.

• Patient assessment: evaluate cardiovascular and neurological status before administration.
• Dose limitation: avoid exceeding the recommended maximum dose for the intended route.
• Concurrent CNS depressants: use with caution as additive effects may occur.
• Elderly or medically compromised patients: consider dose reduction and close monitoring.
• Pregnancy and lactation: reserve use for situations where benefit outweighs potential risk.
• Store at controlled room temperature: keep in original container, protect from light and moisture.

Bupivacaine can interact with other medications, influencing safety and efficacy.

Major Interactions (Avoid)

• Class I antiarrhythmics (e.g., quinidine, procainamide): increase risk of cardiotoxicity.
• Beta‑blockers: may exacerbate bradycardia and hypotension.
• Inhalational anesthetics (e.g., halothane): additive central nervous system depression.

Moderate Interactions (Monitor Closely)

• Opioids: potential additive respiratory depression.
• Calcium channel blockers: may affect cardiac conduction when combined.
• Other local anesthetics: cumulative toxicity risk if combined in the same patient.